In consuming Growth Hormone Releasing Peptide-6 your body is likely to absorb more nitrogen than usual. This in turn facilitates production of protein that can later be used for building muscle mass and burning excess fat in your body. Though it is absolutely safe to consume supplements that are derived from GHRP, the only side effect you may need to deal with is intense hunger that you may experience in as little as half hour of taking the supplement. The silver lining for this drawback is that you can consume lots of foods, especially fruits and vegetables to get the desired results. The contribution made by GHRP 6 towards serving the purpose during workouts is immense.


An intact hypothalamic-pituitary axis is required to achieve the maximal effect of GHSs on GH release. GHRH and somatostatin both influence the action of GHSs, augmenting and diminishing the magnitude of the GH pulse, respectively. When GHRH is administered in combination with GHSs, the effect is synergistic, the magnitude of the GH pulse being greater than that obtained from the sum of the two agents administered separately. GHS stimulation of GH secretion requires the presence of GHRH. In members of a family with a homozygous inactivating mutation of the GHRH receptor, hexarelin was ineffective in stimulating GH release. In addition, children who are GH-deficient as a result of pituitary stalk transsection are unresponsive to GHSs. Thus, somatotroph exposure to GHRH is necessary for GHSs to exert their action.
From the information above we can determine that GHRP-6 is a drug which has some great benefits for the human body. It has in a very short period of time grabbed the attention of athletes and body builders around the world for its all in one utility. Not only is this drugged being used for cutting cycles, it is also being pursued as a stamina booster, muscle booster and a protective agent against weakening of the bones.
Before the discovery of ghrelin, synthetic GH secretagogs were available. Several studies investigated the effects of these substances on human sleep. Oral administration of the GH secretagog MK-677 for 1 week prompts a distinct sleep-promoting effect in healthy young male volunteers, whereas a weak effect is observed in elderly subjects. This study shows that oral administration of a peptide is capable of promoting sleep. After repetitive intravenous administration of GH-releasing peptide 6 (GHRP-6), non-REM sleep stage 2 increases. Similar to the effects of ghrelin in male subjects GH, ACTH, and cortisol are elevated. In a set of studies, the intranasal, oral, and sublingual administration of GHRP-6 was tested. By these routes of administration the effects of the peptide on the sleep EEG and on hormone secretion are less distinct and partly different from those after intravenous injection. In contrast to the sleep-promoting effects of GHRP-6 and ghrelin, hexarelin prompts a decrease of SWS, whereas the pattern of endocrine effects after hexarelin resemble the endocrine changes after ghrelin and GHRP-6 in that there is a marked stimulation of GH. The decrease of SWS after hexarelin may be related to negative feedback inhibition of endogenous GHRH. After a single dose of GHRP-2 during the third period of REM sleep, sleep remains unchanged. The lack of effects in this study may be related to the method that uses only a single injection of the substance.
CJC 1295 has shown some amazing results as a growth hormone releasing hormone (GHRH) analog. Not only has CJC 1295 shown potential to increase growth hormone and IGF-I secretion and effects, but it has been able to do so in very large amounts. CJC 1295 Stimulates Growth Hormone Secretion, and will keep a steady increase of HGH and IGF-1 with no increase in prolactin, leading to fat loss, and increased protein synthesis thereby promoting growth.
For example, there are Growth Hormone Releasing Peptides (GHRP’s with names such as ipamorelin and hexarein) which allow for a slow and steady growth hormone release that produces a pulse which mimics natural growth hormone release times and Growth Hormone Releasing Hormones (GHRH’s such as Mod-GRF) for an even stronger natural release of growth hormone and greater presence of growth hormone precursors known as GH “frags” or fragments.
Thanks to the assiduousness of talented researchers around the globe, our contemporary understanding of the pharmacology and probably also the physiological regulation of growth hormone secretion, came about after the important discovery that GHRP increased pulsatile GH secretion in not only children, but also within normal younger and older men and women. Even though GHRP alone substantially releases GH from the pituitary in vitro without the addition of GHRH, this rhythmic endogenous secretion does require some GHRH.
All relevant GH side effects of numb/tingling hands and arms (especially at night), and water retention will be experienced by the user, but it also has a tremendouse hunger influencing side effect due to its ability to mimic GHRELIN (the hormone that makes our stomach growl and makes us want to eat). Obviously, ravenous hunger isn’t something one would want during a contest diet phase so one might swap from GHRP-6 to GHRP-2, another GH secratagogue which does not make you hungry but which I find is slightly less effective in GH release doses being equal. During the off-season however, hunger can be the bulking bodybuilders’ best friend, so I like to include GHRP-6 solely for this effect in some instances (GH influence aside), in myself and the athletes I help who struggle to find the appetite needed to get through all the food sometimes needed to pack on serious off-season mass.
Used for muscle building, weight loss and anti-aging purposes, this is a very powerful peptide for promoting growth hormone release. GHRP-6 also helps in fighting inflammation and boosting recovery. Some professional bodybuilders are believed to use it together with steroids for greater potency. The peptide not only stimulates the pituitary to produce growth hormone, but also suppresses somatostatin which could impede release.
Abbreviations: AKT1, RAC-alpha serine/threonine-protein kinase; AMI, acute myocardial infarction; CTGF, connective tissue growth factor; DCM, dilated cardiomyopathy; dP/dt, the rate of left ventricle maximal pressure rise in early systole; DX, doxorubicin; ECM, extracellular matrix; EGF, epidermal growth factor; ERK1/2, extracellular signal-regulated kinase 1/2; GH, growth hormone; GHRH, growth hormone-releasing hormone; GHRPs, growth hormone-releasing peptides; GHS, growth hormone secretagogues; GHS-R, growth hormone secretagogue receptor; GHS-R1a, growth hormone secretagogue receptor type 1a; HIF-1α, hypoxia-inducible factor-1 alpha; I/R, ischemia and reperfusion; IGF-1, insulin-like growth factor-1; IL-1β, interleukin-1 beta; IL-6, interleukin 6; LPS, lipopolysaccharide; LV, left ventricle; LVEF, left ventricular ejection fraction; MBP, mean blood pressure; MIF, macrophage migration inhibitory factor; MCP-1, monocyte chemoattractant protein-1; MMP, matrix metalloproteinase; MOD, Multiple Organs Damage; NEP, nitrosylation end products; NIH, National Institute of Health; PDGF, platelet-derived growth factor; PGC1α, peroxisome proliferator-activated receptor gamma coactivator 1 alpha; PI-3K, phosphatidylinositol-4,5-bisphosphate 3-kinase; PPARγ, peroxisome proliferator-activated receptor gamma; RAS, rennin–angiotensin system; rhGH, recombinant human growth hormone; ROS, reactive oxygen species; TGF-β, transforming growth factor beta; TIMP, tissue inhibitor of metalloproteinase; TNF-α, tumor necrosis factor alpha.

To amend Schedule 2 entry to exempt paracetamol when compounded with caffeine, in a powder or granule product containing 1000mg or less of paracetamol and in tablets or capsules containing 500mg or less of paracetamol when paracetamol is the only therapeutic active constituent and when supplied in primary packs of not more than 20 tablets/caplets or 10 sachets of powders/granules.
A seminal report by a Merck Research Laboratories group dated 2003 demonstrated for the first time that chronic treatment with GHRP-6 (21 days) prevented sudden death in a canine model of DCM and subsequently subjected to acute myocardial infarction (AMI). In the meantime, the mortality rates for the vehicle and GH-treated groups were about 50%. Although the authors do not precise the mechanism underlying the 100% survival in the GHRP-6 group, an enhanced regional myocardial compensatory function of the nonischemic zone was assumed.40 This notion could be validated at least in part by the fact that the cardiotropic effects shown by GHRP-1, GHRP-2, GHRP-6, and hexarelin in cardiomyocytes and isolated, denervated, perfused hearts are mediated by an elevation of Ca2+ influx through the voltage-gated calcium channel, triggering Ca2+ release from thapsigargin-sensitive intracellular stores, which translated in a positive inotropic response without a chronotropic effect.41 More recent data confirm the ability of hexarelin and other secretagogue peptides that bind and activate the GHS-R1a, to control the cardiac action potential and reduce apoptosis of cardiomyocytes, derived from isolated hearts subjected to ischemia/reperfusion episodes.42
GHRP was first envisioned to be an analog of GHRH but, from comparison of the activity of GHRH and GHRPs between 1982 and1984, it was hypothesized to reflect the activity of a new hormone regulator of GH secretion, yet to be isolated and identified. Intravenous bolus GHRP releases more GH than GHRH in humans, but the reverse occurs in vitro. GHRPs are pleiotropic peptides with major effects on GH, nutrition, and metabolism, especially as an additional hormone in combination with GHRH as a new regulator of pulsatile GH secretion. The first indication of pleiotropism was an increase of food intake by GHRP. A major reason for the prolonged initial interest in the GHRPs has been its similar, yet different and complementary, action with GHRH on GH regulation and secretion.
If GHRP-6 is powerful for growth hormone release, this peptide is even stronger, albeit slightly so. GHRP-2 is used for similar purposes as the other compound. But it does not fire up appetite as the other peptide is known to do. This may make it more ideal for people interested in improving lean muscle mass. Furthermore, it does not desensitize when taken in low doses without observing breaks as required for other peptides.

MGF stands for mechano growth factor—a peptide derived from insulin-like growth factor-1 (IGF-1), which plays a large role in childhood development and continues to have anabolic effects throughout adulthood. MGF has the ability to encourage repair and growth of wasted tissue through the activation of muscle stem cells, thereby increasing the synthesis of proteins necessary for tissue growth. This peptide is ideal of anyone suffering from muscle loss, either due to old age or a particular condition (i.e., HIV, cancer, etc.)
Boasting similar structure as CJC-1295, sermorelin is commonly used for anti-aging purposes. But it is also considered useful for muscle building. It accounts for 29 amino acids of the 44 that make up growth hormone releasing hormones. This peptide is very potent for improving HGH levels, as shown in studies. It was observed that the 1-29 amino acid chain is mainly responsible for the ability of GHRH to stimulate release of growth hormone by the pituitary. However, sermorelin has very short half-life of about 10 minutes or less.
The conclusion comes down to which peptides should you use. This is going to depend on personal use and experience. Whether you are into bodybuilding, gaining an edge in sports or just looking for health and wellness and anti aging properties, peptides offer a little something for everyone. There are many peptides that are not covered below, but as an introduction into the peptide world these are the most generic and widely used. As with any supplement or drug, please do your own research before diving into using peptides.
Whether it is GHRP 2 or GHRP 6, it is better to get in touch with your physician before you get on with the consumptions of these peptides. In any case, when you are following an exercise regimen of extreme type coupled with special supplements and diets, a complete assessment done by a competent physician is highly recommended. Both the peptides – GHRP 2 and GHRP 6 have their own set of advantages and disadvantages, similarities and differences. It all boils down to individual choices and requirements when it comes to choosing between them.
Remember the GHRP you select is used for a few reasons. One is to prompt the release of the increase pulse in GH you have initiated with the GHRH you have selected to use. This is by inhibition of Somatostatin. So you are actually selecting the timing of the release of your natural production of  still physiologic amount of GH.  Another reason is to actually contribute a little more to the amplitude of you GH pulse.
Melanotan II is an analogue of alpha melanocyte stimulating hormone, the hormone responsible for pigmentation in skin and hair. This peptide has been shown not only to increase skin pigmentation, resulting in a substantially tanner skin tone, but also to stimulate fat loss and increase libido. Its aphrodisiac effects were so substantial that it was the basis for the development of another peptide designed exclusively to address erectile and sexual dysfunction—Bremelanotide PT 141.
In this one you have a peptide with potential to stimulate GH release without resulting in issues associated with others. Just like GHRP-6, it both stimulates the pituitary and suppresses somatostatin. This is not the most powerful growth hormone releasing peptide. But neither causes your appetite to surge drastically nor your prolactin or cortisol levels to rise. These reasons make them a favorite for some users.
Bloating due to water retention: Steroidal administrations such as GHRP-6 use tend to facilitate water retention in the user's body. This leads to sudden swellings in certain areas such as the face, ankles, arms, toes, giving a sort of bloated appearance to the user. Users should take bloating up with his doctor so, that the doctor is able to regulate it.
Now these artificially manufactured compounds can replicate certain hormones within the human body to signal or trigger certain effects. Whereas GH (a total protein hormone of 191 amino acids), can attach to receptors at multiple sites within the body to influence different effects (say muscle cells, bone cells and fats cells, to name but three), shorter peptides have been isolated to trigger certain effects in a specific area/s. Imagine it’s like having a full tool box which you can mend a whole car with, but then you take certain tools out for different jobs and keep them apart in separate drawers which do specific jobs…sort of.
Three of the submissions did not support the proposal highlighting the impact the change in scheduling would have on product currently on the market, industry, pharmacists and consumers. Two submissions noted that there has not been a history of concern with this combination of substances. One submission, referring to the NEJM article, believed that a lack of information about the study means that it cannot be relied upon as there is not a meaningful assessment of the results.
Prolactin, or estrogen gynecomastia issues: Those that are sensitive to prolactin based gynecomastia are open to problems with GHRP-6. Luckily, this is a rare occurrence, and it can be easily combated with dostinex. However, those who stack this compound with anabolic androgenic steroids may have a greater chance of getting gynecomastia. Thats why an AI (aromatase inhibitor) should be used during this kind of cycles.
No growth hormone, or any supplement for that matter, is never going to equate to the same exact results for every user. So, what you experience, is not the same as the next user, and vice-versa. Further, the increase in results and how quickly you will see these results are going to differ for each user. So, make sure you understand this prior to start your dosage, to ensure you are not disappointed if you do not see each one of these benefits, on the very first day that you begin using the Ipamorelin. Also consider the fact that if you use it after food, or with a meal, results will improve. So, proper timing and proper diet and exercise regimen can greatly enhance the results you are going to realize when you are using Ipamorelin as well.
Before the discovery of ghrelin, synthetic GH secretagogs were available. Several studies investigated the effects of these substances on human sleep. Oral administration of the GH secretagog MK-677 for 1 week prompts a distinct sleep-promoting effect in healthy young male volunteers, whereas a weak effect is observed in elderly subjects. This study shows that oral administration of a peptide is capable of promoting sleep. After repetitive intravenous administration of GH-releasing peptide 6 (GHRP-6), non-REM sleep stage 2 increases. Similar to the effects of ghrelin in male subjects GH, ACTH, and cortisol are elevated. In a set of studies, the intranasal, oral, and sublingual administration of GHRP-6 was tested. By these routes of administration the effects of the peptide on the sleep EEG and on hormone secretion are less distinct and partly different from those after intravenous injection. In contrast to the sleep-promoting effects of GHRP-6 and ghrelin, hexarelin prompts a decrease of SWS, whereas the pattern of endocrine effects after hexarelin resemble the endocrine changes after ghrelin and GHRP-6 in that there is a marked stimulation of GH. The decrease of SWS after hexarelin may be related to negative feedback inhibition of endogenous GHRH. After a single dose of GHRP-2 during the third period of REM sleep, sleep remains unchanged. The lack of effects in this study may be related to the method that uses only a single injection of the substance.
Biokey Research TESTO-MAX 20 BRAND: TESTOLONE (RAD140) TESTOLONE (RAD140) Purity : 100% Molecular Formula : C20H16ClN5O2 Molecular Weight: 393.831 CAS#: 1182367-47-0 Description: RAD140 Testolone 30ml @ 20mg per ml Recommended dosage: 0.5-1ml daily DESCRIPTION TESTO-MAX 20 by BioKey Research boasts 20mg/ml of RAD140 which was medically designed to replace testosterone allowing the body to react the same way it would to a healthy dose of the hormone less the…
Side effects resultant from GHRP-6 are typically what would be expected from the use of HGH due to the fact that the end result of GHRP-6 use is that of vastly increased HGH levels. The difference between GHRP-6 and synthetic HGH is, of course, the fact that the HGH resultant from GHRP-6 use is endogenous HGH manufactured by the human body. Nevertheless, GHRP-6 side effects are primarily side effects that occur from HGH use, but there do exist GHRP-6 side effects that are unique to GHRP-6 itself. It is important to note that GHRP-6is not a steroid hormone, nor is it a sex specific hormone, and because of this it can be used by both females and males equally without fear of androgenic or virilization side effects, which GHRP-6 side effects are void of.

Despite the controversies, some scientists continued with additional studies and again proved IGF-1 to actually prolong life…at least in worms.  Then, in 2001, scientists discovered that the use of IGF-1 resulted in a proliferation of cancer cells, especially throughout the breast and colon, and a 2012 study found that both too much or too little IGF-1 could contribute to dying from cancer; implying that IGF-1 actually helped patients with terminal cancer live longer.


Another very positive benefit of CJC1295 is its ability to promote slow wave sleep. Slow wave sleep (SWS) is also known as deep sleep and is the portion of sleep responsible for the highest level of muscle growth and memory retention. SWS is decreased significantly in older adults and also with people who tend to exercise later in the evening.  This peptide has a benefit to side effect ratio that exceeds all others currently being legally sold and would make a great addition to ones training regimen or post cycle therapy.

One more way for growth hormone to help with fat loss is that this sustains the levels of blood glucose through inhibiting glucose uptake to the peripheral cells, reducing the glucose oxidation for the energy in cells and thus boosting the production of the glucose in the cells from amino acids and fats. The blood’s free fatty acids from lipolysis also partially obstruct the insulin receptors on the cell membranes, reducing insulin’s effectiveness in triggering glucose removal from the blood that causes decreased sensitivity to insulin or insulin resistance. These will then result to fat loss, particularly from the difficult to move intra-abdominal storages of fat.
There were concerns regarding the number of contraindications and precautions and whether consumers would be able to interpret these appropriately without a requirement for pharmacist advice. There were concerns regarding gastro-intestinal, renal and other adverse effects related to the potential interactions of ibuprofen and paracetamol. Also raised were concerns regarding the potential for paracetamol overdose.
Taking into account the broad spectrum of TGF-β1 physiology in the fibroblasts/myofibroblasts differentiation events [33], we deem that the reduction of the local scar cellularity and perichondrial matrix accumulation in those animals receiving GHRP-6 could be attributable to TGFB1 transcriptional and functional switch-off. Since the predominant microscopic aspect of the GHRP-6-treated wounds was characterized by meagre cartilage scars, slimmer perichondrium membranes, and far less active cells, we hypothesize that the peptide somehow attenuates the perichondrial activation response to the trauma and/or a possible mesenchyme-to-mesenchyme redifferentiation process, thus lessening the surge of fibroblast and myofibroblasts. In line with this notion, we had documented that GHRP6 prevented hepatic stellate cells activation by reducing CD68, α-SMA, and vimentin local expressions. All these events could be primarily presided by the GHRP-6-related reduction of TGFB1 and CTGF expression in both parenchymal and nonparenchymal cells [7].
A remarkable specific (125)I-Tyr-Ala-hexarelin binding was observed in the human cardiovascular system where the highest binding levels were detected in ventricles, followed by atria, aorta, coronaries, carotid, endocardium, and vena cava. In other experiments on H9c2, cardiomyocyte-specific GHRP binding was found along with a potent antiapoptotic activity.3 The primarily investigated receptor was the growth hormone secretagogue receptor type 1a (GHS-R1a), which was detected in isolated human cardiomyocytes, myocardium, and aorta samples.17 It has been recently shown that GHS-R1a is a sort of “promiscuous receptor” involved in many systems and behavioral patterns such as reward, feeding, and memory, which makes it an attractive pharmacological target.18 Years later, the synthetic GHRP hexarelin was acknowledged as a ligand of another protein identified as CD36, a scavenger receptor that is expressed in various tissues, including monocytes/macrophages and the endothelial microvasculature. Activation of CD36 in perfused hearts by hexarelin was shown to increase coronary perfusion pressure in a dose-dependent manner. Contrariwise, this effect was lacking in hearts from CD36-null mice and hearts from spontaneous hypertensive rats genetically deficient in CD36.19,20 Thus, it is currently accepted that two cardiac receptor subtypes mediate the pharmacological actions of GHRP-6, GHRP-2, and hexarelin.21,22
×